Evidence map›Paper›PMID 41665694›Full record

ArticleCancer causes & control : CCC2026

Associations of epidemiologic risk factors with Fusobacterium nucleatum and bacterial alpha diversity in the colorectal tumor-associated microbiota.

Courtney M Hill, Rachel C Malen, Adriana M Reedy, Orsalem Kahsai, Keith Curtis, Ningxin Ma, Timothy W Randolph, Jing Ma, Claire E Thomas, Shuji Ogino and 5 more

Abstract read
In one paragraph

Article in Cancer causes & control : CCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Medicina (Kaunas, Lithuania) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Courtney M HillDepartment of Epidemiology, University of Washington, Seattle, WA, 98105, USA. chill7@uw.edu.
Rachel C MalenFred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
Adriana M ReedyFred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
Orsalem KahsaiFred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
Keith CurtisFred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
Ningxin MaFred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
Timothy W RandolphFred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
Jing MaFred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
Claire E ThomasFred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
Shuji OginoProgram in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02215, USA.
John D PotterDepartment of Epidemiology, University of Washington, Seattle, WA, 98105, USA.
Daniel D BuchananColorectal Oncogenomics Group, Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Parkville, Australia.
Polly A NewcombDepartment of Epidemiology, University of Washington, Seattle, WA, 98105, USA.
Meredith A J HullarFred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
Amanda I PhippsDepartment of Epidemiology, University of Washington, Seattle, WA, 98105, USA.

Funding

Data sharing: the Colon Cancer Family Registry CohortU01CA167551 · NCI · UNIVERSITY OF MELBOURNE · PI Daniel David BUCHANAN, Steven Gallinger · 2018 to 2026
$16.8M
Contributing Factors and Consequences of Cancer Health DisparitiesT32CA094880 · NCI · UNIVERSITY OF WASHINGTON · PI Christopher I Li, AMANDA IRENE PHIPPS · 2017 to 2026
$3.7M
Bacterial correlates of colorectal cancer subgroups and survivalR01CA217970 · NCI · UNIVERSITY OF WASHINGTON · PI PHIPPS, AMANDA IRENE · 2018 to 2022
$3.2M
Hormones and Colon Cancer: Epigenetic Subtypes, Risk, and SurvivalR01CA076366 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NEWCOMB, POLLY A · 1998 to 2009
$2.4M
American Cancer Society CRP-24-1185864-01-PROFCancer Research UK Grand Challenge Award C10674/A27140CCR NIH HHS U01CA167551NCI NIH HHS R01 CA076366NCI NIH HHS R01CA076366NCI NIH HHS R01 CA217970NCI NIH HHS R01CA217970NCI NIH HHS T32 CA094880NCI NIH HHS T32CA094880NCI NIH HHS U01 CA167551
6 · The paper itself

Abstract

backgroundAspects of the gut microbiome, including presence of specific bacterial species and overall community structure, have been linked to the etiology and prognosis of colorectal cancer (CRC). Less is known about the epidemiologic risk factors that are associated with the composition of the microbiota in invasive colorectal tumors.

methodsUsing tumor and paired normal colorectal tissue samples from a subset of participants in the population-based Seattle Colon Cancer Family Registry, we compared the presence of Fusobacterium nucleatum (F. nucleatum) (n = 898) measured via droplet digital PCR and alpha diversity (Shannon index) (n = 611) measured via 16S rRNA gene sequencing in colorectal tissue across demographics, health behaviors, and neighborhood socioeconomic status (nSES).

resultsNormalized counts of F. nucleatum were consistently higher in tumor tissue than in patient-matched normal tissue across all risk factors, while alpha diversity was lower. Female sex was associated with high presence and enrichment of F. nucleatum in tumor tissue (odds ratio [OR] 1.61; 95% confidence interval [CI] 1.02, 2.54 and OR 1.58, 95% CI 1.10, 2.27, respectively). Relative to those aged 40-49 years, the youngest age group (< 40 years) had lower alpha diversity in tumor tissue (OR for highest vs. lowest tertile: 0.33; 95% 0.13, 0.83). Other factors, including diet, were not related to F. nucleatum presence or tumor tissue alpha diversity.

conclusionBy uncovering epidemiologic risk factors for F. nucleatum presence and bacterial diversity in the intratumoral microbiota, this work informs our understanding of associations of the gut microbiota with CRC etiology and outcomes.

Indexed as

Colorectal NeoplasmsFusobacterium InfectionsFusobacterium nucleatumGastrointestinal MicrobiomeAdultAgedFemaleHumansMaleMiddle AgedRisk FactorsRNA, Ribosomal, 16SRNA, Ribosomal, 16S16S rRNA gene sequencingBacterial diversityCRCddPCRDietFusobacteriumIntratumoral microbiomePhysical activitySCCFRSocioeconomic status

Identifiers

PMID41665694
PMCPMC12891059

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.